Vinay Prasad’s memo makes alarming claims about the COVID-19 vaccine — including the assertion, made without any supporting ...
Massachusetts Institute of Technology professor Phillip Sharp co-founded Alnylam with several others in 2002. It wasn't Sharp ...
An internal memo written by the Food and Drug Administration's top vaccine regulator offers a concerning glimpse into the future of vaccine regulation in the US -- and could have profound implications ...
Paris: French multinational pharmaceutical giant, Sanofi, has announced the completion of its acquisition of Vicebio Ltd.This ...
News-Medical.Net on MSNOpinion
In RFK Jr.’s upside-down world of vaccines, panel votes to end hepatitis B shot at birth
Recent weeks have brought good news about vaccines, with studies indicating that flu vaccination reduces heart disease, ...
The prolonged uncertainty surrounding CureVac's future has concluded. BioNTech, the Mainz-based vaccine developer, has successfully cleared the final hurdle to acquire its Tübingen rival. With more ...
12hon MSN
Notable healthcare headlines for the week: UnitedHealth, Eli Lilly, and Bristol Myers in focus
Wall Street's major averages closed in the green on Friday, as traders assessed fresh inflation data in hopes of gauging the Federal Reserve's monetary policy. The benchmark S&P 500 closed +0.2%, ...
At this year's ASH congress, the results of the phase 1b/2 DURGA-1 of AZD0120 – a dual BCMA and CD19-directed CAR-T therapy – ...
Anti-CD19 panCARTM program (ORN-252) demonstrated robust B cell depletion with significant reduction in anti-dsDNA titers in humanized lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback